APOMORPHINE EMETIC TABLETS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apomorphine emetic tablets

jurox pty limited - apomorphine hydrochloride - oral tablet - apomorphine hydrochloride alkaloid active 6.5 mg/tb - central nervous system - dog | bitch | castrate | puppy - emetic | induce vomiting

Apomorphine HCl Sterop 5 mg/ml inj./inf. sol. s.c. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apomorphine hcl sterop 5 mg/ml inj./inf. sol. s.c. amp.

laboratoires sterop sa-nv - apomorphine hydrochloride 5 mg/ml - solution for injection/infusion - 5 mg/ml - apomorphine hydrochloride 5 mg/ml - apomorphine

APOMORPHINE WOCKHARDT apomorphine hydrochloride hemihydrate 10 mg/mL solution for injection or infusion ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

apomorphine wockhardt apomorphine hydrochloride hemihydrate 10 mg/ml solution for injection or infusion ampoule

wockhardt bio pty ltd - apomorphine hydrochloride hemihydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - apomorphine wockhardt solution for injection or infusion is indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.

APOMINE apomorphine hydrochloride hemihydrate 100 mg/20 mL solution for infusion vial Australia - English - Department of Health (Therapeutic Goods Administration)

apomine apomorphine hydrochloride hemihydrate 100 mg/20 ml solution for infusion vial

interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; hydrochloric acid; water for injections - indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.

Apomorphine New Zealand - English - Medsafe (Medicines Safety Authority)

apomorphine

max health limited - apomorphine hydrochloride 5 mg/ml - solution for infusion - 5 mg/ml - active: apomorphine hydrochloride 5 mg/ml excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection - apomorphine is indicated to reduce the number and severity of 'off' phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during 'on' phases.

Apomorphine hydrochloride 5mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

apomorphine hydrochloride 5mg/ml solution for infusion

pharmaceuticals sales & development sweden ab (pharmswed) - apomorphine hydrochloride hemihydrate - solution for infusion - 5 milligram(s)/millilitre - dopamine agonists; apomorphine

Apomorphine hydrochloride 5 mg/ml solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

apomorphine hydrochloride 5 mg/ml solution for infusion

evolan pharma ab - apomorphine hydrochloride hemihydrate - solution for infusion - 5 milligram(s)/millilitre - dopamine agonists; apomorphine

APOMINE Intermittent apomorphine hydrochloride hemihydrate 30mg/3mL injection cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

apomine intermittent apomorphine hydrochloride hemihydrate 30mg/3ml injection cartridge

interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 10 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; hydrochloric acid - apomorphine injection is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

MOVAPO PFS apomorphine hydrochloride hemihydrate 50mg/10mL solution for subcutaneous infusion pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

movapo pfs apomorphine hydrochloride hemihydrate 50mg/10ml solution for subcutaneous infusion pre-filled syringe

stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid - movapo pfs is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.

APO-GO Israel - English - Ministry of Health

apo-go

abic marketing ltd, israel - apomorphine hydrochloride - solution for injection / infusion - apomorphine hydrochloride 10 mg/ml - apomorphine - apomorphine - treatment of motor fluctuations (“on-off” phenomena) in patients with parkinson's disease which are not sufficiently controlled by oral anti-parkinson medication.